)

NeuroMetrix (NURO) investor relations material
NeuroMetrix Q3 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Q3 2024 revenue declined 51% year-over-year to $0.6M, mainly due to lower DPNCheck sales from adverse Medicare Advantage reimbursement changes and international distributor inventory issues, with Quell sales providing a minor offset.
Net loss for Q3 2024 was $1.5M ($0.75/share), improved from $1.8M ($1.66/share) in Q3 2023, as operating expenses fell 25% year-over-year due to headcount reduction and cost-cutting measures.
Gross profit dropped 60% year-over-year, with gross margin contracting to 53.1% from 65.0%, reflecting lower DPNCheck sales and product mix.
The company is conducting a strategic review, including potential asset sales, mergers, or changes in marketing, with no set timetable for completion.
Company is actively reviewing strategic alternatives to enhance shareholder value.
Financial highlights
Q3 2024 revenue: $0.6M (down 51% year-over-year); nine months ended September 30, 2024: $2.5M (down 47%).
Q3 2024 gross profit: $0.3M (down 60% year-over-year); gross margin 53.1% vs. 65.0% prior year.
Q3 2024 operating expenses: $2.1M (down 25% year-over-year); nine months: $8.1M (down 3%).
Q3 2024 net loss: $1.5M; nine months: $6.0M (vs. $4.9M prior year).
Cash, cash equivalents, and marketable securities at September 30, 2024: $14.8M; working capital: $15.6M; no debt.
Outlook and guidance
Management expects current cash and securities to fund operations for at least the next twelve months.
DPNCheck Medicare Advantage sales are unlikely to recover near-term due to ongoing CMS reimbursement changes; international DPNCheck sales expected to resume in early 2025 as distributor inventory normalizes.
Quell Rx for fibromyalgia is in controlled launch; De Novo application for Quell-CIPN planned for late 2024 or early 2025.
Company continues to pursue opportunities in alternative markets for DPNCheck.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage